Acute Treatment with Lauric Acid Reduces Blood Pressure and Oxidative Stress in Spontaneously Hypertensive Rats

Basic Clin Pharmacol Toxicol. 2017 Apr;120(4):348-353. doi: 10.1111/bcpt.12700. Epub 2017 Jan 5.

Abstract

The effects of acute administration of lauric acid (LA), the most abundant medium-chain fatty acid of coconut oil, on blood pressure, heart rate and oxidative stress were investigated in spontaneously hypertensive rats (SHR). Intravenous doses of LA reduced blood pressure in a dose-dependent fashion (1, 3, 4, 8 and 10 mg/kg) in both SHR and Wistar Kyoto rats. LA (10-8 to 3 × 10-3 M) induced vasorelaxation in isolated superior mesenteric artery rings of SHR in the presence (n = 7) or absence (n = 8) of functional endothelium [maximum effect (ME) = 104 ± 3 versus 103 ± 4%]. After exposure to KCl (60 mM), LA also induced concentration-dependent vasorelaxation (n = 7) compared to that under Phe-induced contraction (ME = 113.5 + 5.1 versus 104.5 + 4.0%). Furthermore, LA-induced vasorelaxation in vessels contracted with S(-)-BayK8644 (200 nM), a L-type Ca2+ channel agonist (ME = 91.4 + 4.3 versus 104.5 + 4.0%, n = 7). Lastly, LA (10-3 M) reduced NADPH-dependent superoxide accumulation in the heart (18 ± 1 versus 25 ± 1 MLU/min/μg protein, n = 4, p < 0.05) and kidney (82 ± 3 versus 99 ± 4 MLU/min/μg protein, n = 4, p < 0.05). Our data show that LA reduces blood pressure in normotensive and hypertensive rats. In SHR, this effect might involve Ca+2 channels in the resistance vessels and by its capability of reducing oxidative stress in heart and kidneys.

MeSH terms

  • Animals
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use*
  • Blood Pressure / drug effects*
  • Dose-Response Relationship, Drug
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism
  • Heart Rate / drug effects
  • Hypertension / drug therapy*
  • Hypertension / metabolism
  • In Vitro Techniques
  • Injections, Intravenous
  • Lauric Acids / administration & dosage
  • Lauric Acids / therapeutic use*
  • Mesenteric Artery, Superior / drug effects
  • Oxidative Stress / drug effects*
  • Rats, Inbred SHR
  • Rats, Inbred WKY
  • Superoxides / metabolism
  • Vasoconstrictor Agents / pharmacology
  • Vasodilation / drug effects

Substances

  • Antioxidants
  • Lauric Acids
  • Vasoconstrictor Agents
  • Superoxides
  • lauric acid